List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 23 studies with search of: ThromboGenics
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
Condition: Stroke, Acute
Intervention: Drug: Microplasmin
2 Completed Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402
Condition: Healthy
Intervention: Drug: Administration of recombinant FVIII/placebo in healthy male subjects treated with TB-402
3 Completed Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.
Condition: Symptomatic Vitreomacular Adhesion
Intervention: Drug: Microplasmin
4 Terminated Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT
Condition: Deep Vein Thrombosis
Intervention: Drug: microplasmin
5 Completed Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
Condition: Total Knee Replacement Surgery
Interventions: Drug: TB-402;   Drug: Enoxaparin
6 Completed Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion
Condition: Focal Vitreomacular Adhesion
Intervention: Drug: Microplasmin
7 Completed A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)
Condition: Vitreomacular Traction
Intervention: Drug: Microplasmin
8 Recruiting Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Condition: Vitreomacular Adhesion Including Macular Hole
Interventions: Drug: Ocriplasmin;   Other: Sham injection
9 Recruiting Safety and Efficacy Study of Intravitreal Microplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
Conditions: Exudative Age-Related Macular Degeneration;   Focal Vitreomacular Adhesion
Interventions: Drug: Microplasmin;   Drug: Sham injection
10 Completed A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With DME
Condition: Diabetic Macular Edema
Interventions: Drug: Microplasmin;   Other: Sham injection
11 Recruiting Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery
Condition: Prophylaxis of Venous Thromboembolic Events
Interventions: Drug: TB-402;   Drug: Rivaroxaban
12 Completed A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)
Condition: Vitreoretinal Disorders
Intervention: Drug: Microplasmin
13 Completed Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.
Condition: Symptomatic Vitreomacular Adhesion
Intervention: Drug: microplasmin
14 Recruiting Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy
Condition: Vitrectomy
Interventions: Drug: Microplasmin;   Drug: Placebo
15 Completed The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)
Condition: Primary Pars Plana Vitrectomy
Intervention: Drug: ocriplasmin
16 Terminated Intra-Arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion
Condition: Stroke
Intervention: Drug: Microplasmin
17 Completed Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
Conditions: Vitreomacular Traction Maculopathy;   Eye Diseases
Intervention: Drug: Microplasmin
18 Completed Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin
Condition: Healthy
Intervention: Drug: LWMH in TB-402 treated subjects or TB-402 in warfarin treated subjects
19 Completed Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies
Condition: Symptomatic Vitreomacular Adhesion
Intervention:
20 Terminated Intra-Arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion
Condition: Arterial Occlusive Diseases
Intervention: Drug: Microplasmin

Previous Page Studies Shown (1-20) Next Page (21-23)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services